Cluster-Randomized Trial Comparing Ambulatory Decision Support Tools to Improve Heart Failure Care

J Am Coll CardiolPublished Cluster-randomised controlled trial

Authors' conclusion

An automated, patient-specific, electronic health record-embedded alert increased MRA prescribing compared to both a message and usual care.

Study context

Population
Adults with heart failure with reduced ejection fraction (HFrEF), no active MRA prescription, no contraindication to mineralocorticoid receptor antagonists (MRAs), and an outpatient cardiologist in a large health system
Participants
2,211 adults
Comparison
EHR-embedded alert vs message vs usual care on MRA prescribing
  • Alertn = 755
  • Messagen = 812
  • Usual caren = 644reference
Primary endpoint
New MRA prescribing
Methodological details3-arm, pragmatic, cluster-randomized by cardiologist (60 per arm)
  • 3-arm
  • Pragmatic
  • Cluster-randomized by cardiologist (60 per arm)

Primary result

As reported in the abstract

Relative risk (95% CI)P value
Alert vs Usual care
2.53(1.77–3.62)
P < 0.0001
Alert vs Message
1.67(1.21–2.29)
P = 0.002
NNT with alert for an additional MRA prescription
5.6

Original publication

Cluster-Randomized Trial Comparing Ambulatory Decision Support Tools to Improve Heart Failure Care. J Am Coll Cardiol. Published 5 March 2023. doi:10.1016/j.jacc.2023.02.005

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.